Evidence map›Paper›PMID 23661800›Full record

ArticleThe Journal of infectious diseases2013

Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease.

Nell S Lurain, Barbara A Hanson, Jeffrey Martinson, Sue E Leurgans, Alan L Landay, David A Bennett, Julie A Schneider

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04449926 (BCG and Plasma Amyloid in Non-Demented Adults), which is not on this map. Cited by 83 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04449926 phase2completednot on this mapstarted 2020, after this paper: background citation

BCG and Plasma Amyloid in Non-Demented Adults

TypeinterventionalSponsorMindful Diagnostics and Therapeutics, LLCRan2020 to 2021Enrolled49ConditionsAlzheimer Disease, Late OnsetArmsBacillus of Calmette and Guerin (BCG)
3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 1 synthesis or guideline pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Increased Amyloidogenic Neuronal Injury in HIV-1-infected APP-KI Alzheimer's disease mice.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Viruses · 2024
    Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Nell S LurainDepartment of Immunology/Microbiology, Rush University Medical Center, Chicago, Illinois 60612, USA. nlurain@rush.edu
Barbara A Hanson
Jeffrey Martinson
Sue E Leurgans
Alan L Landay
David A Bennett
Julie A Schneider
Rush University · USRush University Medical Center · USUniversity of Illinois Chicago · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1991 to 2020
$49.1M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
NIA NIH HHS P30 AG010161NIA NIH HHS P30AG10161NIA NIH HHS R01 AG015819NIA NIH HHS R01AG15819
6 · The paper itself

Abstract

Serum, cerebrospinal fluid (CSF), and cryopreserved lymphocytes from subjects in the Rush Alzheimer's Disease Center Religious Orders Study were analyzed for associations between cytomegalovirus (CMV) infection and clinical and pathological markers of Alzheimer disease. CMV antibody levels were associated with neurofibrillary tangles (NFTs). CSF interferon γ was only detected in seropositive subjects and was significantly associated with NFTs. The percentage of senescent T cells (CD4+ or CD8+CD28-CD57+) was significantly higher for CMV-seropositive as compared to CMV-seronegative subjects and was marginally associated with the pathologic diagnosis of Alzheimer disease (CD4+) or amyloid-β (CD8+). Immunocytochemical analysis showed induction of amyloid-β in human foreskin fibroblasts (HFFs) infected with each of 3 clinical CMV strains. In the same subjects, there was no association of herpes simplex virus type 1 (HSV-1) antibody levels with CMV antibody levels or clinical or pathological markers of Alzheimer disease. HSV-1 infection of HFFs did not induce amyloid-β. These data support an association between CMV and the development of Alzheimer disease.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesAntibodies, ViralCytomegalovirus InfectionsFemaleFibroblastsHumansInterferon-gammaMaleNeurofibrillary TanglesT-Lymphocyte SubsetsAmyloid beta-PeptidesAntibodies, ViralInterferon-gammaAlzheimer's diseaseamyloid-βCD28-/CD57+ T cellscytomegalovirusinterferon-gamma

Identifiers

PMID23661800
PMCPMC3719902
OpenAlexW2151190343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.